US Stock Insider Trading | Pulse Biosciences discloses 2 insider transactions on February 23

K-LinePoet · 2026-02-27T11:15:12+00:00

Pulse BioScience (PLSE) recently disclosed internal trading activity of executive Danahy Kevin Patrick. He sold 5,000 shares and bought 5,000 shares on February 18, 2026, at a selling price of $23.64 and a buying price of $1.53. The company focuses on the medical device field, utilizing nano pulse electrical signal technology.

K-LinePoet

2026-02-27 11:15:12

Abstract generation in progress

On February 23, 2026, Pulse Biological Sciences (PLSE) disclosed two insider trading transactions. Executive Danahy Kevin Patrick sold 5,000 shares on February 18, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 23, 2026	Executive	Danahy Kevin Patrick	February 18, 2026	Buy	5,000	1.53	7,650.00
February 23, 2026	Executive	Danahy Kevin Patrick	February 18, 2026	Sell	5,000	23.64	$118,200
February 17, 2026	Executive	Danahy Kevin Patrick	February 12, 2026	Sell	20,000	23.37	$467,400
February 17, 2026	Executive	Danahy Kevin Patrick	February 13, 2026	Sell	20,000	23.53	$470,600
February 17, 2026	Executive	Danahy Kevin Patrick	February 17, 2026	Sell	20,000	23.63	$472,600
February 17, 2026	Executive	Danahy Kevin Patrick	February 17, 2026	Buy	60,000	1.53	$91,800
February 11, 2026	Executive	Danahy Kevin Patrick	February 9, 2026	Sell	20,000	21.45	$429,000
February 11, 2026	Executive	Danahy Kevin Patrick	February 10, 2026	Sell	20,000	23.52	$470,400
February 11, 2026	Executive	Danahy Kevin Patrick	February 11, 2026	Buy	60,000	1.53	$91,800
February 11, 2026	Executive	Danahy Kevin Patrick	February 11, 2026	Sell	20,000	25.20	$504,000

[Company Profile]

Pulse Biological Sciences, Inc., registered in Nevada on May 19, 2014, under the name Electroblate, Inc., is a medical device company developing a new proprietary platform technology called NanoPulse Electrical Stimulation (NPES) for biomedical applications. Electroblate, Inc. was renamed Pulse Biological Sciences, effective December 8, 2015.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.